Archive for the ‘Pregnancy’ Category

14% and 10% Drop in Fertility in Germany and Sweden After COVID Shot Program

Here come the data…..

Fertility declines near the end of the COVID-19 pandemic: Evidence of the 2022 birth declines in Germany and Sweden

Bujard, Martin; Andersson, Gunnar (2022)

BiB Working Paper 6/2022. WiesbadenBundesinstitut für Bevölkerungsforschung

“Following the onset of the COVID-19 pandemic, several countries faced short-term fertility declines in 2020 and 2021, a development which did not materialize in Scandinavian and German-speaking countries. However, more recent birth statistics show a steep fertility decline in the aftermath of the pandemic in 2022. We aim to provide data on the unexpected birth decline in 2022 in Germany and Sweden and relate these data to pandemic-related contextual developments which could have influenced the post-pandemic fertility development. We rely on monthly birth statistics and present seasonally adjusted monthly Total Fertility Rates (TFR) for Germany and Sweden. We relate the nine-months lagged fertility rates to contextual developments regarding COVID-19 mortality and morbidity, unemployment rates, and COVID-19 vaccinations.

The seasonally adjusted monthly TFR of Germany dropped from 1.5-1.6 in 2021 to 1.3-1.4 in 2022, a decline of about 14%. In Sweden, the corresponding TFR dropped from about 1.7 in 2021 to 1.5-1.6 in 2022, a decline of almost 10%. There is no association of the fertility trends with changes in unemployment, infection rates, or COVID-19 deaths. However, there is a strong association between the onset of vaccination programmes and the fertility decline nine months after of this onset. The fertility decline in the first months of 2022 in Germany and Sweden is remarkable. Common explanations of fertility change during the pandemic do not apply in its aftermath. The association between the onset of mass vaccinations and subsequent fertility decline indicates that people adjusted their behaviour to get vaccinated before becoming pregnant, as societies were opening up with post-pandemic life conditions. Our study provides novel information on fertility declines in countries previously not affected by any COVID-19 baby bust. We provide a first appraisal of the COVID-19-fertility nexus in the immediate aftermath of the pandemic.”

For more:

CoQ10: What is It & Do You Need It?

CoQ10: What is it & Do You Need It?

By Holtdorf Medical Group

Do You Need CoQ10?

As the body ages, many systems and functions begin to decline and deteriorate. Common problems associated with aging include reduced energy, cognitive troubles, fertility issues, and of course greater risk of cardiovascular and neurodegenerative disease. Many assume that these difficulties are an unavoidable part of getting older. However, this may not be the case.

Is CoQ10 the Answer?

CoQ10 is a substance that naturally occurs in the body and is an important part of healthy bodily function. As we get older, levels of CoQ10 decline, which can contribute to various difficulties and health issues associated with aging. By maintaining or restoring appropriate levels of CoQ10 through effective supplementation, you may be able to significantly reduce the risk of age-related issues and support long-term wellness. CoQ10 influences many bodily functions but perhaps its greatest impact is on energy production. CoQ10 is stored in mitochondria, which are responsible for producing cellular energy in the form of adenosine triphosphate (ATP). ATP is the most widely utilized form of energy throughout the body. CoQ10 is necessary for ATP production. Therefore, without an adequate supply of CoQ10, cells can experience a cellular energy deficit resulting in widespread dysfunction. Issues associated with poor CoQ10 levels include heart disease, fibromyalgia, neurological and neurodegenerative disorders, diabetes, muscle conditions, cancer, and others.

Getting the CoQ10 Your Body Needs

Most individuals are able to acquire enough CoQ10 to maintain healthy bodily functions. However, tissue levels of CoQ10 decline with age. Other factors including nutrient deficiencies, genetic issues, mitochondrial disease, medications such as statins, and oxidative stress can further contribute to CoQ10 deficiency. Despite CoQ10 being found in common foods including beef, chicken, fish, and whole grains, there are many individuals who suffer from a deficiency. Part of the reason may be that CoQ10 has a low absorption rate when acquired from food sources. Because of this, an individual may have poor CoQ10 levels even if they consume a high volume of foods containing CoQ10. An effective and safe solution to poor CoQ10 acquisition is supplementing with a product such as HoltraCeuticals’ CoQ10 Plus. CoQ10 Plus is a supplement that provides high-quality and easily absorbed CoQ10.

HoltraCeuticals developed the supplement with the goal of improving individual wellness and longevity. To achieve this goal, specific elements have been included in CoQ10 Plus. CoQ10 Plus utilizes soft gel capsules that improve absorption, meaning that the CoQ10 contained within is more easily utilized by the body. CoQ10 Plus also contains Vitamin E, which has been shown to work synergistically with CoQ10. Studies show that the combination of these two substances provides better absorption and greater antioxidant action than if they were to be taken separately. Greater absorption and quality ingredients make CoQ10 Plus an exceptional supplement that can be used to support long-term wellness.

Benefits of Supplementing with CoQ10

Supplementing with CoQ10 provides a wide range of benefits that support sustained wellness and longevity. Its influence can be seen in areas including metabolic activity, antioxidant action, and safeguarding heart health. Below are several areas that are benefited by supplementing with CoQ10.

Combatting Free Radical Damage

Free radicals cause oxidative damage, which is a primary contributor to issues and disorders commonly associated with aging. An excess of free radicals can cause oxidative damage, which weakens cell membranes, damages DNA, and disrupts cell function. When maintained at the appropriate volume, CoQ10 within mitochondria protects against free radicals and other agents of oxidation. Therefore, supplementing with CoQ10 may provide protection against age-related illness and dysfunction.

Protecting Against Neurological Disorders

Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are triggered by a lack of energy in brain cells. As mentioned above, mitochondria are the primary producers of cellular energy. Mitochondrial function declines with age due in part to oxidation. In addition to cellular damage, oxidation triggers the production of harmful substances that disrupt neurological function. Such disruption can cause a reduction in memory, motor skills, and cognitive ability. Supplementing with CoQ10 helps protect mitochondrial function and may reduce the production of neurological-disrupting substances, thereby limiting the progression of neurodegenerative disease.

Reducing Risk of Heart Disease

A major contributor to heart disease is oxidative damage and inflammation in veins and arteries. Once these elements reach a certain threshold, they can inhibit the heart’s ability to contract and relax. This results in heart failure or stroke. There is a notable concentration of CoQ10 in the cardiovascular muscle that helps prevent oxidation and inflammation that can lead to cardiovascular episodes. Supplementing with CoQ10 can help protect heart health by combating oxidative and inflammatory agents in veins, arteries, and heart muscles.

Combatting Infertility

Supplementing with CoQ10 may be able to resolve infertility issues in both men and women. In men, sperm count and quality declines with age, due primarily to oxidative damage. Similarly, women experience a decline in egg production and quality as oxidative damage accrues. Regardless of gender, the antioxidant properties of CoQ10 help protect against oxidation that contributes to infertility.

Reducing Headaches & Migraines

Those who are deficient in CoQ10 frequently experience headaches and migraines. Poor mitochondrial activity can increase cellular uptake of calcium resulting in greater production of free radicals and reduced antioxidant activity. When the mitochondria in brain cells become damaged or disrupted due to increased oxidation, the brain becomes starved for energy. An energy deficit in the brain can trigger headaches and migraines. As a guardian of mitochondrial activity, CoQ10 safeguards cellular activity, limits inflammation, and supports energy production in the brain. The protective action of CoQ10 may help limit cognitive difficulties and reduce the occurrence of migraines or other head pains.

Support Sustained Wellness with CoQ10 Plus

Aging is a major concern for many people. Fortunately, it is possible to combat the oxidative damage that causes the many troubles associated with growing older. CoQ10 is a critical precursor enzyme produced by the body that supports and protects many systems including the heart and brain. Ensuring that the body has an adequate supply of this important substance protects against incremental oxidative damage and promotes long term wellness. Safeguard your future health by supplementing with a high-quality CoQ10 supplement such as HoltraCeuticals’ CoQ10 Plus

Holtorf Medical GroupThe Holtorf Medical Group specializes in optimizing quality of life and being medical detectives to uncover the underlying cause of symptoms, rather than just prescribing medications to cover-up the symptoms. We are experts in natural, prescription bioidentical hormone replacement and optimization, complex endocrine dysfunction, fibromyalgia, chronic fatigue syndrome and Lyme disease. We’ve dedicated our practice to providing you the best in evidenced-based, integrative medicine that’s not only safe and effective, but provides measurable results.

Spotting the Target: Clinical Clues in the Diagnosis of Disseminated Lyme Disease in Pregnancy

Spotting the target: clinical clues in the diagnosis of disseminated Lyme disease in pregnancy

Published:March 18, 2022 DOI:

A 33-year-old G2P1 woman at 33 weeks’ gestation presented with 10 days of bifrontal headache despite treatment with sertraline, butalbital-acetaminophen-caffeine, and prochlorperazine and 2 days of pruritic body rash (Figure 1).

Blood pressure and urine protein: creatinine ratio were within normal limits, but she had mild transaminitis. Her rash was originally thought to be caused by a drug-induced hypersensitivity reaction, however, in addition to a generalized morbilliform eruption, a physical examination revealed a large annular erythematous patch with a dusky center on the left popliteal fossa (Figure 2)  and similar smaller annular lesions on the buttocks and legs (Figures 3 and 4).

The findings of large and multiple erythema migrans lesions and associated headache prompted a high suspicion for disseminated Lyme disease with neurologic involvement. Serum tests for Lyme disease, including whole-cell enzyme-linked immunosorbent assay and Western blot (for immunoglobulins M and G), were positive. A lumbar puncture revealed elevated red blood cells and nucleated cells in the cerebrospinal fluid consistent with neurologic involvement of Lyme disease. The patient recovered with intravenous ceftriaxone for 2 weeks for disseminated Lyme disease. She delivered a healthy baby boy at 40 weeks’ gestation.

(See link for article)



Unfortunately many do not remain “recovered” after only 2 weeks of antibiotics.  This woman and her baby need to be watched over time.  If mysterious, migrating symptoms continue – they need retreatment.

This is a perfect example of a glaring problem with Lyme/MSIDS.  Mainstream medicine treats it as they do other infections when this is a relapsing illness that is stealthy, embeds itself in the human body, (making it hard for treatments to reach it) is often polymicrobial (numerous pathogens that require different medications), is pleomorphic (changes forms) so the body can’t recognize it as a “bad guy,” and is often relapsing (reappears) at a later date due to stress when the body is in a weakened state.

Please read a few articles to understand these issues better:

For more on Lyme/MSIDS in pregnancy:

Lyme in Pregnancy: Associations With Parent & Offspring Health Outcomes – An International Cross-sectional Survey

Front. Med., 03 November 2022
Sec. Infectious Diseases – Surveillance, Prevention and Treatment

Lyme borreliosis in pregnancy and associations with parent and offspring health outcomes: An international cross-sectional survey

  • 1McMaster Midwifery Research Centre, McMaster University, Hamilton, ON, Canada
  • 2LymeHope, Ontario, ON, Canada
  • 3Department of Biology, Mount Allison University, Sackville, NB, Canada
  • 4Dean Center for Tick Borne Illness, Spaulding Rehabilitation Hospital, Boston, MA, United States
  • 5Invisible International, Cambridge, MA, United States
  • 6G. Magnotta Lyme Disease Research Lab, Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada
  • 7Centre Hospitalier Universitaire (CHU) Sainte-Justine, Montréal, QC, Canada
  • 8Department of Obstetrics and Gynecology, Université de Montréal, Montréal, QC, Canada
  • 9Trent/Fleming School of Nursing, Trent University, Peterborough, ON, Canada

Background: Lyme disease (LD) is a complex tick-borne pathology caused by Borrelia burgdorferi sensu lato bacteria. Currently, there are limited data regarding the health outcomes of people infected during pregnancy, the potential for perinatal transmission to their fetus, and the long-term effects on these children. Therefore, the primary objective of this survey study was to investigate the impact of LD in pregnancy on both the parent and their offspring.

Methods: A seven-section survey was developed and administered in REDCap. Although recruitment was primarily through LD-focused organizations, participation was open to anyone over the age of 18 who had been pregnant. Participant health/symptoms were compared across those with “Diagnosed LD,” “Suspected LD,” or “No LD” at any time in their lives. The timing of LD events in the participants’ histories (tick bite, diagnosis, treatment start, etc.) were then utilized to classify the participants’ pregnancies into one of five groups: “Probable Treated LD,” “Probable Untreated LD,” “Possible Untreated LD,” “No Evidence of LD,” and “Unclear.”

Results: A total of 691 eligible people participated in the survey, of whom 65% had Diagnosed LD, 6% had Suspected LD, and 29% had No LD ever. Both the Diagnosed LD and Suspected LD groups indicated a high symptom burden (p < 0.01). Unfortunately, direct testing of fetal/newborn tissues for Borrelia burgdorferi only occurred following 3% of pregnancies at risk of transmission; positive/equivocal results were obtained in 14% of these cases. Pregnancies with No Evidence of LD experienced the fewest complications (p < 0.01) and were most likely to result in a live birth (p = 0.01) and limited short- and long-term offspring pathologies (p < 0.01). Within the LD-affected pregnancy groups, obtaining treatment did not decrease complications for the parent themselves but did ameliorate neonatal health status, with reduced rates of rashes, hypotonia, and respiratory distress (all p < 0.01). The impact of parent LD treatment on longer-term child outcomes was less clear.

Conclusion: Overall, this pioneering survey represents significant progress toward understanding the effects of LD on pregnancy and child health. A large prospective study of pregnant people with LD, combining consistent diagnostic testing, exhaustive assessment of fetal/newborn samples, and long-term offspring follow-up, is warranted.



And that long-term offspring follow-up will never happen unless independent researchers take it upon themselves.  Our government just wants this to all go away – except for acute cases for which a lucrative “vaccine,” can be created, which is always viewed as a magic-bullet and will be a cash-cow with big profit margins.

The little we know about congenital Lyme has come primarily from Dr. Jones, RIP and a nurse who personally gathered all the research done on congenital Lyme disease out of the goodness of her heart and out of necessity for her own family.  This is typically how we finally get some answers, and frankly the best way to get real answers that are helpful.

Aren’t you tired of funding research with our tax dollars that doesn’t help patients?

For more:

Hospital Whistleblower On Significant Decrease in Birth Rates, Increase in Stillbirths & VAIDS


Go here for:  Exclusive: Leaked Hospital Memo Reveals 500 Percent Rise in Stillbirths; Fetal Specialist Explains Likely Cause  Video Here (Approx. 22 Min)

Hospital Whistleblower Exposes Fetal Death Coverup

A nurse whistleblower from California states that stillbirths used to be extremely uncommon, but her hospital had 22 stillbirths in one month, and are now projected to increase each month.  Go here for the Epoch Times article.  The whistleblower’s mother passed away due to the Fauci Death Protocol still being used in hospitals despite being extremely toxic and ineffective.

Forty-three year old veteran OBGYN, Dr. James A. Thorp, is seeing death and destruction like never before due to the COVID “vaccines” which cause a significant inflammatory affect.

  • 12,000 fold increase in menstrual abnormalities
  • Dr. Thorp spoke of whistleblower Dr. Kimberly Biss (OBGYN) who in this Youtube states she is seeing:
    • 50% increase in infertility
    • 50% increase in miscarriages
    • 25% increase in abnormal pap smears & cervical malignancies
  • Dr. Thorp is also seeing an increase in fetal malformation, cardiac arrest, placental thrombosis, and VAIDS (vaccine induced acquired immune deficiency).
  • Despite all these horrific outcomes it is occurring globally.

Died Suddenly will stream November 21, 2022 on The Stew Peters Network.  Sign up here for notifications:

For more: